The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Peptide design for antimicrobial and immunomodulatory applications
Open accessAbstract
The increasing threat of antibiotic resistance in pathogenic bacteria and the dwindling supply of antibiotics available to combat these infections poses a significant threat to human health throughout the world. Antimicrobial peptides (AMPs) have long been touted as the next generation of antibiotics capable of filling the anti‐infective void. Unfortunately, peptide‐based antibiotics have yet to realize their potential as novel pharmaceuticals, in spite of the immense number of known AMP sequences and our improved understanding of their antibacterial mechanism of action. Recently, the immunomodulatory properties of certain AMPs have become appreciated. The ability of small synthetic peptides to protect against infection in vivo has demonstrated that modulation of the innate immune response is an effective strategy to further develop peptides as novel anti‐infectives. This review focuses on the screening methods that have been used to assess novel peptide sequences for their antibacterial and immunomodulatory properties. It will also examine how we have progressed in our ability to identify and optimize peptides with desired biological characteristics and enhanced therapeutic potential. In addition, the current challenges to the development of peptides as anti‐infectives are examined and the strategies being used to overcome these issues are discussed. © 2013 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 100: 572–583, 2013.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Self-citationAntimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Self-citationAntibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Understanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Self-citationSurvival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Self-citationCationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Self-citationYang, D., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., & Chertov, O. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1069 · Cited by 1,240
The role of cationic antimicrobial peptides in innate host defences
Hancock, R. E. W., & Diamond, G. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01823-0 · Cited by 1,218
Self-citationInnate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action
Chan, D. I., Prenner, E. J., & Vogel, H. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.04.006 · Cited by 1,039
APD2: the updated antimicrobial peptide database and its application in peptide design.
Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941
The clinical impact of bacterial biofilms
Høiby, N., Ciofu, O., Johansen, H. K., Song, Z., Moser, C., Jensen, P. Ø., Molin, S., Givskov, M., Tolker‐Nielsen, T., & Bjarnsholt, T. (2011) · International Journal of Oral Science · doi:10.4248/ijos11026 · Cited by 894
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
Koczulla, R., von Degenfeld, G., Kupatt, C., Krötz, F., Zahler, S., Gloe, T., Issbrücker, K., Unterberger, P., Zaiou, M., Lebherz, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17545 · Cited by 863
APD: the Antimicrobial Peptide Database
Wang, Z. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh025 · Cited by 808
Bals, R., Wang, X., Zasloff, M., & Wilson, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9541 · Cited by 746
Frank, R. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00137-0 · Cited by 741
The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses
Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., & Hancock, R. E. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3883 · Cited by 713
Self-citationHuman Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
Self-citationAll-D amino acid-containing channel-forming antibiotic peptides.
Wade, D., Boman, A., Wåhlin, B., Drain, C. M., Andreu, D., Boman, H. G., & Merrifield, R. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4761 · Cited by 677
Multifunctional cationic host defence peptides and their clinical applications
Yeung, A. T. Y., Gellatly, S. L., & Hancock, R. E. W. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0710-x · Cited by 610
Self-citationGentilucci, L., De Marco, R., & Cerisoli, L. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793292555 · Cited by 586
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Vandamme, D., Landuyt, B., Luyten, W., & Schoofs, L. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.009 · Cited by 567
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Self-citationde la Fuente-Núñez, C., Korolik, V., Bains, M., Nguyen, U., Breidenstein, E. B. M., Horsman, S., Lewenza, S., Burrows, L., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-12 · Cited by 459
Self-citationAntimicrobial Properties of Lysozyme in Relation to Foodborne Vegetative Bacteria
Masschalck, B., & Michiels, C. W. (2003) · Critical Reviews in Microbiology · doi:10.1080/713610448 · Cited by 442
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37
Schmidtchen, A., Frick, I., Andersson, E., Tapper, H., & Björck, L. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03146.x · Cited by 439
An anti-infective peptide that selectively modulates the innate immune response
Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1288 · Cited by 403
Self-citationTjabringa, G. S., Aarbiou, J., Ninaber, D. K., Drijfhout, J. W., Sørensen, O. E., Borregaard, N., Rabe, K. F., & Hiemstra, P. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6690 · Cited by 391
Gao, G., Lange, D., Hilpert, K., Kindrachuk, J., Zou, Y., Cheng, J. T. J., Kazemzadeh-Narbat, M., Yu, K., Wang, R., Straus, S. K., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.013 · Cited by 388
Self-citationHigh-throughput generation of small antibacterial peptides with improved activity
Hilpert, K., Volkmer-Engert, R., Walter, T., & Hancock, R. E. W. (2005) · Nature Biotechnology · doi:10.1038/nbt1113 · Cited by 375
Self-citationImpact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
Self-citationAntimicrobial activity of synthetic magainin peptides and several analogues.
Zasloff, M., Martin, B., & Chen, H. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.910 · Cited by 373
Clinical Development of Cationic Antimicrobial Peptides: From Natural to Novel Antibiotics
Hancock, R., & Patrzykat, A. (2002) · Current Drug Target -Infectious Disorders · doi:10.2174/1568005024605855 · Cited by 365
Self-citationCherkasov, A., Hilpert, K., Jenssen, H., Fjell, C. D., Waldbrook, M., Mullaly, S. C., Volkmer, R., & Hancock, R. E. W. (2009) · ACS Chemical Biology · doi:10.1021/cb800240j · Cited by 357
Self-citationβ-Defensins: Multifunctional Modulators of Infection, Inflammation and More?
Semple, F., & Dorin, J. R. (2012) · Journal of Innate Immunity · doi:10.1159/000336619 · Cited by 346
Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs
Nguyen, L. T., Chau, J. K., Perry, N. A., de Boer, L., Zaat, S. A. J., & Vogel, H. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012684 · Cited by 333
Antimicrobial peptide mimics for improved therapeutic properties
Rotem, S., & Mor, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.020 · Cited by 296
All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistance
(1990) · FEBS Letters · doi:10.1016/0014-5793(90)81351-n · Cited by 294
Soman, N. R., Baldwin, S. L., Hu, G., Marsh, J. N., Lanza, G. M., Heuser, J. E., Arbeit, J. M., Wickline, S. A., & Schlesinger, P. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38842 · Cited by 293
Raguse, T. L., Porter, E. A., Weisblum, B., & Gellman, S. H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0270423 · Cited by 283
Braff, M. H., Hawkins, M. A., Nardo, A. D., Lopez-Garcia, B., Howell, M. D., Wong, C., Lin, K., Streib, J. E., Dorschner, R., Leung, D. Y. M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4271 · Cited by 275
Lactoferrin, a bird’s eye view
Vogel, H. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o2012-016 · Cited by 260
Cationic Host Defence Peptides: Multifaceted Role in Immune Modulation and Inflammation
Choi, K.-Y., Chow, L. N. Y., & Mookherjee, N. (2012) · Journal of Innate Immunity · doi:10.1159/000336630 · Cited by 240
Antibiotics: Where did we go wrong?
Overbye, K. M., & Barrett, J. F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03285-4 · Cited by 223
Nijnik, A., Madera, L., Ma, S., Waldbrook, M., Elliott, M. R., Easton, D. M., Mayer, M. L., Mullaly, S. C., Kindrachuk, J., Jenssen, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901813 · Cited by 216
Self-citationPotential of immunomodulatory host defense peptides as novel anti-infectives
Easton, D. M., Nijnik, A., Mayer, M. L., & Hancock, R. E. W. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.07.004 · Cited by 215
Self-citationTherapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections
J. Afacan, N., T.Y. Yeung, A., M. Pena, O., & E.W. Hancock, R. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799277617 · Cited by 193
Sequence Requirements and an Optimization Strategy for Short Antimicrobial Peptides
Hilpert, K., Elliott, M. R., Volkmer-Engert, R., Henklein, P., Donini, O., Zhou, Q., Winkler, D. F. H., & Hancock, R. E. W. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.08.014 · Cited by 183
Self-citationA review: The active peptide of lactoferrin
TOMITA, M., TAKASE, M., BELLAMY, W., & SHIMAMURA, S. (1994) · Pediatrics International · doi:10.1111/j.1442-200x.1994.tb03250.x · Cited by 180
Nell, M. J., Tjabringa, G. S., Wafelman, A. R., Verrijk, R., Hiemstra, P. S., Drijfhout, J. W., & Grote, J. J. (2006) · Peptides · doi:10.1016/j.peptides.2005.09.016 · Cited by 174
Action mechanism of tachyplesin I and effects of PEGylation
Imura, Y., Nishida, M., Ogawa, Y., Takakura, Y., & Matsuzaki, K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.005 · Cited by 173
Structural Studies of a Peptide with Immune Modulating and Direct Antimicrobial Activity
Wieczorek, M., Jenssen, H., Kindrachuk, J., Scott, W. R. P., Elliott, M., Hilpert, K., Cheng, J. T. J., Hancock, R. E. W., & Straus, S. K. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.007 · Cited by 166
Self-citationLewenza, S., Falsafi, R. K., Winsor, G., Gooderham, W. J., McPhee, J. B., Brinkman, F. S. L., & Hancock, R. E. W. (2005) · Genome Research · doi:10.1101/gr.3513905 · Cited by 165
Self-citationIntracellular Receptor for Human Host Defense Peptide LL-37 in Monocytes
Mookherjee, N., Lippert, D. N. D., Hamill, P., Falsafi, R., Nijnik, A., Kindrachuk, J., Pistolic, J., Gardy, J., Miri, P., Naseer, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802586 · Cited by 163
Self-citationNagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., Tanaka, S., & Heumann, D. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.5.972-982.2002 · Cited by 160
Bommarius, B., Jenssen, H., Elliott, M., Kindrachuk, J., Pasupuleti, M., Gieren, H., Jaeger, K.-E., Hancock, R. E. W., & Kalman, D. (2010) · Peptides · doi:10.1016/j.peptides.2010.08.008 · Cited by 159
Self-citationBeyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches
Giuliani, A., & Rinaldi, A. C. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0717-3 · Cited by 159
Tomasinsig, L., Pizzirani, C., Skerlavaj, B., Pellegatti, P., Gulinelli, S., Tossi, A., Virgilio, F. D., & Zanetti, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802185200 · Cited by 158
Innate Defense Regulator Peptide 1018 in Wound Healing and Wound Infection
Steinstraesser, L., Hirsch, T., Schulte, M., Kueckelhaus, M., Jacobsen, F., Mersch, E., Stricker, I., Afacan, N. J., Jenssen, H., Hancock, R. E. W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039373 · Cited by 151
Self-citationLau, Y. E., Rozek, A., Scott, M. G., Goosney, D. L., Davidson, D. J., & Hancock, R. E. W. (2004) · Infection and Immunity · doi:10.1128/iai.73.1.583-591.2005 · Cited by 145
Self-citationImproved activity of a synthetic indolicidin analog
Falla, T. J., & Hancock, R. E. W. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.771 · Cited by 127
Self-citationRivas-Santiago, B. T., Castañeda‐Delgado, J. E., Rivas-Santiago, C., Waldbrook, M., Gonzalez-Curiel, I. E., León‐Contreras, J. C., Enciso‐Moreno, J. A., del Villar, V., Mendez-Ramos, J., Hancock, R. E. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059119 · Cited by 124
Self-citationZhang, L., Scott, M. G., Yan, H., Mayer, L. D., & Hancock, R. E. W. (2000) · Biochemistry · doi:10.1021/bi0011173 · Cited by 122
Self-citationLL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs
Lai, Y. Y., Adhikarakunnathu, S., Bhardwaj, K., Ranjith-Kumar, C. T., Wen, Y., Jordan, J. L., Wu, L. H., Dragnea, B. G., Mateo, L. S., & Kao, C. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026632 · Cited by 122
Easy Strategy To Increase Salt Resistance of Antimicrobial Peptides
Yu, H., Tu, C.-H., Yip, B., Chen, H., Cheng, H.-T., Huang, K.-C., Lo, H., & Cheng, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00202-11 · Cited by 119
Oral delivery of peptides and proteins using lipid-based drug delivery systems
Li, P., Nielsen, H. M., & Müllertz, A. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.717068 · Cited by 116
Improved Derivatives of Bactenecin, a Cyclic Dodecameric Antimicrobial Cationic Peptide
Wu, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1274 · Cited by 112
Self-citationMookherjee, N., Hamill, P., Gardy, J. L., Blimkie, D., Falsafi, R., Chikatamarla, A., Arenillas, D. J., Doria, S., Kollmann, T. R., & Hancock, R. E. W. (2009) · Molecular BioSystems · doi:10.1039/b813787k · Cited by 111
Self-citationWang, J., Wong, E. S. W., Whitley, J. C., Li, J., Stringer, J. M., Short, K. R., Renfree, M. B., Belov, K., & Cocks, B. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024030 · Cited by 107
Berthold, N., Czihal, P., Fritsche, S., Sauer, U., Schiffer, G., Knappe, D., Alber, G., & Hoffmann, R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01923-12 · Cited by 105
QSAR modeling and computer‐aided design of antimicrobial peptides
Jenssen, H., Fjell, C. D., Cherkasov, A. R., & Hancock, R. E. W. (2007) · Journal of Peptide Science · doi:10.1002/psc.908 · Cited by 100
Self-citationSynthetic Cationic Peptide IDR-1018 Modulates Human Macrophage Differentiation
Pena, O. M., Afacan, N. J., Pistolic, J., Chen, C. C. L., Madera, L., Falsafi, R., Fjell, C. D., & Hancock, R. E. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052449 · Cited by 98
Self-citationThe Antimicrobial Peptide Cathelicidin Protects Mice from Escherichia coli O157:H7-Mediated Disease
Chromek, M., Arvidsson, I., & Karpman, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046476 · Cited by 96
Achtman, A. H., Pilat, S., Law, C. W., Lynn, D. J., Janot, L., Mayer, M. L., Ma, S., Kindrachuk, J., Finlay, B. B., Brinkman, F. S. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003515 · Cited by 94
Self-citationSequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide
Yu, H. B., Kielczewska, A., Rozek, A., Takenaka, S., Li, Y., Thorson, L., Hancock, R. E. W., Guarna, M. M., North, J. R., Foster, L. J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.073627 · Cited by 84
Self-citationFalciani, C., Lozzi, L., Pollini, S., Luca, V., Carnicelli, V., Brunetti, J., Lelli, B., Bindi, S., Scali, S., Giulio, A. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046259 · Cited by 84
Garlapati, S., Garg, R., Brownlie, R. M., Latimer, L. J. P., Simko, E., Hancock, R. E. W., Babiuk, L. A., Gerdts, V., Potter, A. A., & den Hurk, S. V. D. L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.011 · Cited by 69
Self-citationGarlapati, S., Eng, N. F., Kiros, T. G. G., Kindrachuk, J., Mutwiri, G., Hancock, R. E. W., Halperin, S. A., Potter, A. A., Babiuk, L. A., & Gerdts, V. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.009 · Cited by 68
Self-citationNanotools for the Delivery of Antimicrobial Peptides
Urban, P., Valle‐Delgado, J. J., Moles, E., Marques, J., Diez, C., & Fernàndez‐Busquets, X. (2012) · Current Drug Targets · doi:10.2174/138945012802002302 · Cited by 66
Gyssens, I. C. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.002 · Cited by 63
Jenssen, H., Lejon, T., Hilpert, K., Fjell, C. D., Cherkasov, A. R., & Hancock, R. E. W. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00543.x · Cited by 62
Self-citationStructure-Activity Relationships of Antibacterial Acyl-Lysine Oligomers
Radzishevsky, I. S., Kovachi, T., Porat, Y., Ziserman, L., Zaknoon, F., Danino, D., & Mor, A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.03.006 · Cited by 61
Killing of Trypanosomatid Parasites by a Modified Bovine Host Defense Peptide, BMAP-18
Haines, L. R., Thomas, J. M., Jackson, A., Eyford, B. A., Razavi, M., Watson, C. N., Gowen, B. E., Hancock, R. E. W., & Pearson, T. W. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000373 · Cited by 60
Self-citationTurner-Brannen, E., Choi, K.-Y. G., Lippert, D. N. D., Cortens, J. P., Hancock, R. E. W., El-Gabalawy, H. S., & Mookherjee, N. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3440 · Cited by 50
Self-citationModification of Antimicrobial Peptide with Low Molar Mass Poly(ethylene glycol)
Zhang, G., Han, B., Lin, X., Wu, X., & Yan, H. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn134 · Cited by 46
Kindrachuk, J., Scruten, E., ATTAH‐POKU, S. K., Bell, K., Potter, A. A., Babiuk, L. A., Griebel, P. J., & Napper, S. (2010) · Biopolymers · doi:10.1002/bip.21441 · Cited by 45
Gao, G., Cheng, J., Kindrachuk, J., Hancock, R. E. W., Straus, S. K., & Kizhakkedathu, J. N. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.015 · Cited by 44
Self-citationCherkasov, A. (2005) · International Journal of Molecular Sciences · doi:10.3390/i6010063 · Cited by 39
Synthetic Immunomodulatory Peptide IDR-1002 Enhances Monocyte Migration and Adhesion on Fibronectin
Madera, L., & Hancock, R. E. W. (2012) · Journal of Innate Immunity · doi:10.1159/000338648 · Cited by 37
Self-citationHealth economic issues in the treatment of drug-resistant serious Gram-positive infections
Nathwani, D. (2009) · Journal of Infection · doi:10.1016/s0163-4453(09)60007-4 · Cited by 22
The cathelicidin-like peptide derived from panda genome is a potential antimicrobial peptide
Yan, X., Zhong, J., Liu, H., Liu, C., Zhang, K., & Lai, R. (2011) · Gene · doi:10.1016/j.gene.2011.11.009 · Cited by 12
Cited by
Kumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Zaky, A. A., Simal-Gandara, J., Eun, J.-B., Shim, J.-H., & Abd El-Aty, A. M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.815640 · Cited by 440
Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions
Raheem, N., & Straus, S. K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02866 · Cited by 369
Reassessing the Host Defense Peptide Landscape
Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00043 · Cited by 359
Self-citation
Metadata
- Authors
- Haney, E. F., & Hancock, R. E. W.
- Venue
- Peptide Science
- Publisher
- Wiley
- Published
- 2013-11
- Volume
- 100
- Issue
- 6
- Pages
- 572-583
- ISSN
- 0006-3525 (ISSN-L)
- OpenAlex
- W1790693342
- Cited by
- 291
- References
- 96
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.